(Q40806534)

23 September 2017

Suicide attempts, platelet monoamine oxidase and the average evoked response (English)

1 reference

23 September 2017

0 references

1 reference

Buchsbaum MS

1

1 reference

23 September 2017

Haier RJ

series ordinal

2

1 reference

23 September 2017

Murphy DL

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 July 1977

1 reference

Acta Psychiatrica Scandinavica

23 September 2017

1 reference

23 September 2017

56

1 reference

23 September 2017

69-79

1 reference

23 September 2017

1

1 reference

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

23 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Letter: Brain-levels of monoamine oxidase in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Lowered monoamine oxidase activity in brains from alcoholic suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

A study of selected catecholamine metabolizing enzymes: a comparison of depressive suicides and alcoholic suicides with controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Eye-Tracking Patterns in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Reduced MAO activity in first-degree relatives of individuals with bipolar affective disorders. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Neuromuscular dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Monamine oxidase in schizophrenia and other behavioral disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Multiple forms of brain monoamine oxidase in schizophrenic and normal individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Suicide in childhood and early adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Evoked Potential Tests of Augmenting-Reducing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Clinical criteria for psychiatric diagnosis and DSM-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Low platelet monoamine oxidase activity and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

Sensation seeking and cortical augmenting-reducing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB06665.X

10.1111/J.1600-0447.1977.TB06665.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference